Pain News and Research

Latest Pain News and Research

CML treatment-free remission criteria outlined

Treatment-free remission may be feasible in many patients with chronic myeloid leukaemia, say researchers who set out clinical and logistical requirements for discontinuing tyrosine kinase inhibitor therapy.

18 May 2016

Study demonstrates effectiveness of NeuroStar TMS Therapy System in women with postpartum depression

An unfortunate fact facing mothers in the U.S. is that postpartum depression is the most common complication of childbirth. Approximately 10 to 15 percent of women who give birth each year – or roughly 600,000 women – experience postpartum depression symptoms.

18 May 2016

The world's first Hackathon for chronic pain

Definition - A hackathon (also known as a hack day, hackfest or codefest) is an event in which computer programmers and others involved in software development and hardware development collaborate intensively on software projects.

18 May 2016

RDAVR system improves survival of patients with severe aortic stenosis

When replacing a defective aortic valve with a new one, restoring function is the first priority. However, variables such as durability, length of surgery, duration of heart stoppage, size of the surgical incision, postoperative pain, and complications are other important considerations.

17 May 2016

Exposing headache sufferers to pure-wavelength green light can lessen severity of migraines

Most migraine and post-traumatic headache sufferers find their headaches get worse in light, leading them to quit their most fundamental daily tasks and seek the comfort of darkness.

17 May 2016

Experimental hepatitis C drug slows down development of Zika in mice

Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of Virology and Chemotherapy.

17 May 2016

WHO/PAHO statement on Zika virus and the 2016 Rio Olympic and Paralympic Games

The World Health Organization (WHO) and the Pan American Health Organization (PAHO) recognize that athletes and visitors are seeking more information on the risks of Zika and ways to prevent infection while attending the 2016 Rio Olympic and Paralympic Games (5 August to 18 September 2016).

16 May 2016

GammaCore both effective and cost effective for the treatment of cluster headache

A paper in the Journal of Headache and Pain reports that non-invasive stimulation of the vagus nerve (nVNS) is a cost effective therapy for cluster headache. These findings were based on reductions in medication use and improvements in quality of life. The publication also notes that further economic benefits would have been found had reduced visits to clinics been taken into account.

16 May 2016

Pluristem completes enrollment in Phase II intermittent claudication trial

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea.

16 May 2016

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos Therapeutics, Inc., a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD), today announced that Adzenys XR-ODT™ is in distribution channels and is now available to prescribe for patients with ADHD in the United States.

16 May 2016

Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

New analyses presented at the American Thoracic Society’s 2016 annual conference (ATS 2016) further add to the efficacy and safety profile of OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF).

16 May 2016

Better self-care and patient education can improve treatment for chronic pain

The National Pain Strategy, released this year by the U.S. Department of Health and Human Services, places strong emphasis on self management and patient education as critical pathways for improving treatment of chronic pain, especially the leading malady, back pain.

15 May 2016

Combination of COX-2-selective NSAID with PPI can reduce risk of stomach, intestinal ulcers

Non-steroidal anti-inflammatory drugs (NSAIDs)—including ibuprofen, diclofenac, naproxen and others—are commonly used pain medications that are generally safe but may increase the risk of developing stomach and intestinal ulcers.

13 May 2016

BetterYou Magnesium Oil spray relieves migraine pain in 43-year old mum

A 43-year old mum of one from Bristol, who suffered from frequent painful migraines for almost a decade has found relief thanks to BetterYou™ Magnesium Oil spray.

From BetterYou Ltd 13 May 2016

Rotavirus vaccine program reduces hospitalization rates by more than 70% in Ontario

Hospitalization for rotavirus infections decreased by > 70% following the introduction of a vaccine program in Ontario, Canada, according to a study published May 11, 2016 in the open-access journal PLOS ONE by Sarah Wilson from Public Health Ontario and the Institute for Clinical Evaluative Sciences, Canada, and colleagues.

13 May 2016

Mosquito larvae carries Sindbis virus that can cause Ockelbo disease

After an outbreak of Ockelbo disease in northern Sweden in 2013, researchers at Umeå University were able to trace the virus to mosquitos in an area of Lövånger. In a new study, researchers have shown that mosquito larvae in the Västerbotten region also carry virus that can cause infectious disease. These include the Sindbis virus, which causes Ockelbo disease, which is associated with fever, rashes and prolonged joint pain.

13 May 2016

Clinical study shows sitagliptin drug not effective in treating NAFLD

A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.

13 May 2016

Drug-repositioning strategy could help combat Chikungunya virus

Since 2013, the mosquito-borne Chikungunya virus has spread rapidly through South America and the Caribbean, and is now threatening Southern Europe and the southern US.

13 May 2016

Researchers develop bio-glass material that mimics real cartilage

Scientists have developed a material that can mimic cartilage and potentially encourage it to re-grow.

12 May 2016

New survey shows many adults unaware of common asthma symptoms

A new national asthma survey commissioned by National Jewish Health shows that many adults are unaware of common symptoms of asthma in adults. Doctors say that the findings explain why many adults with asthma may not realize that they have the disease, and don't seek treatment that can help them.

11 May 2016

Pain News and Research

Latest Pain News and Research

CML treatment-free remission criteria outlined

Study demonstrates effectiveness of NeuroStar TMS Therapy System in women with postpartum depression

The world's first Hackathon for chronic pain

RDAVR system improves survival of patients with severe aortic stenosis

Exposing headache sufferers to pure-wavelength green light can lessen severity of migraines

Experimental hepatitis C drug slows down development of Zika in mice

WHO/PAHO statement on Zika virus and the 2016 Rio Olympic and Paralympic Games

GammaCore both effective and cost effective for the treatment of cluster headache

Pluristem completes enrollment in Phase II intermittent claudication trial

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

Better self-care and patient education can improve treatment for chronic pain

Combination of COX-2-selective NSAID with PPI can reduce risk of stomach, intestinal ulcers

BetterYou Magnesium Oil spray relieves migraine pain in 43-year old mum

Rotavirus vaccine program reduces hospitalization rates by more than 70% in Ontario

Mosquito larvae carries Sindbis virus that can cause Ockelbo disease

Clinical study shows sitagliptin drug not effective in treating NAFLD

Drug-repositioning strategy could help combat Chikungunya virus

Researchers develop bio-glass material that mimics real cartilage

New survey shows many adults unaware of common asthma symptoms

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in